The CADY SOLO HIV 1/2 Rapid Test Kit is an in-vitro rapid diagnostic screening device. It is designed for the quick, qualitative detection of antibodies against Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2).
Key Features
-
Sample Flexibility: The test can process human whole blood, serum, or plasma specimens.
-
Methodology: It uses a chromatographic immunoassay (lateral flow) system to screen for HIV antibodies.
-
High Accuracy: Engineered for highly accurate, preliminary point-of-care screening.
How to Understand the Results
The test cassette features a Control (C) line and a Test (T) line:
-
Negative: Only one colored line appears in the Control (C) zone. No line appears in the Test (T) zone.
-
Positive: Two separate colored lines appear—one in the Control (C) zone and another in the Test (T) zone.
-
Invalid: The test is invalid if no line appears in the Control (C) zone, even if a line shows up in the Test (T) zone. An invalid test means you need to retest with a new device.
Critical Clinical Context
-
Screening Only: This kit offers a preliminary screening result. It cannot be used as the sole criteria to diagnose an HIV infection.
-
Confirmatory Testing Required: If your test returns a positive result, you must seek professional medical care to get a confirmatory laboratory test, such as an ELISA or Western Blot analysis.
-
The Window Period: Rapid antibody tests rely on your body producing measurable defenses against the virus. Because antibodies can take anywhere from 21 to 90 days after an exposure to reach detectable levels, a negative test may not reflect a very recent exposure.
